Structure Therapeutics American Stock Price on December 9, 2024
| GPCR Stock | 27.90 2.07 6.91% |
If you're considering investing in Structure Stock, it is important to understand the factors that can impact its price. As of today, the current price of Structure Therapeutics stands at 27.90, as last reported on the 20th of December, with the highest price reaching 30.88 and the lowest price hitting 27.48 during the day. Structure Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13% return per unit of risk over the last 3 months. Structure Therapeutics American exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Structure Therapeutics' Risk Adjusted Performance of (0.04), coefficient of variation of (1,525), and Variance of 18.18 to confirm the risk estimate we provide.
At this time, Structure Therapeutics' Issuance Of Capital Stock is relatively stable compared to the past year. . At this time, Structure Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 12/20/2024, Price To Book Ratio is likely to grow to 3.47, while Price Earnings To Growth Ratio is likely to drop (0.24). Structure Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Structure |
Sharpe Ratio = -0.1314
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GPCR |
Estimated Market Risk
| 4.26 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.56 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Structure Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Structure Therapeutics by adding Structure Therapeutics to a well-diversified portfolio.
Price Book 1.7827 | Book Value 9.761 | Enterprise Value 687.8 M | Enterprise Value Ebitda (13.46) | Shares Float 153.5 M |
Related Headline
Biomea Fusion Headline on 9th of December 2024
Biomea Fusion Announces Preliminary Data from Ongoing COVALE... by finance.yahoo.com
Preliminary data supports BMF-500s potential as a transformative therapy for patients with FLT3 mutated relapsed or refractory acute leukemiaBMF-500 showed a favorable safety and tolerability profile, with no dose-limiting toxicities observed across all dose levelsPharmacokinetic and pharmacodynamic data confirmed on-target FMS-like tyrosine kinase 3 inhibition, demonstrating dose-proportional activity and good compartmental penetrationPreliminary Phase I data for BMF-500 in RR ac
Structure Therapeutics Valuation on December 9, 2024
It is possible to determine the worth of Structure Therapeutics on a given historical date. On December 9, 2024 Structure was worth 35.5 at the beginning of the trading date compared to the closed value of 34.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Structure Therapeutics stock. Still, in general, we apply an absolute valuation method to find Structure Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Structure Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Structure Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 32.55 | 33.56 | 32.17 | 33.35 | 830,088 | |
12/09/2024 | 35.50 | 36.42 | 34.70 | 34.72 | 1,734,909 |
| 35.00 | 36.15 | 34.10 | 34.70 | 423,007 |
| Backtest Structure Therapeutics | | | Structure Therapeutics History | | | Structure Therapeutics Valuation | Previous | Next |
Structure Therapeutics Trading Date Momentum on December 9, 2024
| On December 10 2024 Structure Therapeutics American was traded for 34.70 at the closing time. The top price for the day was 36.15 and the lowest listed price was 34.10 . The trading volume for the day was 423 K. The trading history from December 10, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.06% . The trading price change against the current closing price is 21.03% . |
Structure Therapeutics Fundamentals Correlations and Trends
By evaluating Structure Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Structure Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Structure financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Structure Therapeutics Stock history
Structure Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Structure is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Structure Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Structure Therapeutics stock prices may prove useful in developing a viable investing in Structure Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 36.7 M | 40.3 M | |
| Net Loss | -39.4 M | -41.4 M |
Structure Therapeutics Quarterly Net Working Capital |
|
Structure Therapeutics Stock Technical Analysis
Structure Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Structure Therapeutics Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
Structure Therapeutics American cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Structure Therapeutics December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Structure Therapeutics shares will generate the highest return on investment. By undertsting and applying Structure Therapeutics stock market strength indicators, traders can identify Structure Therapeutics American entry and exit signals to maximize returns
Structure Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Structure Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Structure Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Structure to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.42) | |||
| Treynor Ratio | (0.22) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.